Ovala, Inc.
Biotechnology · PITTSBURGH, PA
BiotechnologySEC Form D
Ovala, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 31, 2026, reporting $3,257,155 raised toward a $12,957,155 offering.
Incorporated in Delaware and based in PITTSBURGH, PA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Ovala, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Stephen BollingerExecutive Officer · Director
- Brad PetersenDirector
- Richard PetersenDirector
- Michael TovianDirector
- Christopher PetersenDirector
- John SippleExecutive Officer
- Jeffrey QuillenDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised